Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is Phase I/IIa First-in-Human Study of \[212Pb\]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Tumors
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek minimum 18 lat
- •Potwierdzony nowotwór neuroendokrynny (NET) lub oponiak, wcześniej nie leczony tym rodzajem terapii
- •Guz zaawansowany, nieusuwany chirurgicznie lub z przerzutami
- •Widoczna choroba w badaniach obrazowych (CT lub MRI) wykonanych w ciągu ostatnich 2 miesięcy
- •Guz wykazuje cechy progresji (pogorszenia) w ciągu ostatniego roku
- •Potwierdzenie w badaniu PET, że komórki nowotworu mogą być trafione nowym lekiem
- •Dobry stan ogólny zdolności do codziennego funkcjonowania (skala ECOG 0-1)
- •Możliwość czasowego wstrzymania leczenia somatostatyną (28 dni przed każdą dawką leku)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 90 Years
- Last updated (source)
- October 13, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (20)
Mayo Clinic
Jacksonville, United States
Biogenix Molecular
Miami, United States
Advent Health Radiation Oncology at Central Florida
Orlando, United States
The University of Chicago
Chicago, United States
University of Iowa
Iowa City, United States
University of Kentucky
Lexington, United States
Johns Hopkins
Baltimore, United States
Barbara Ann Karmanos Cancer Institute
Detroit, United States
BAMF Health
Grand Rapids, United States
Michigan Health Professionals
Troy, United States
Mayo Clinic
Rochester, United States
Washington University
St Louis, United States
Nebraska Cancer Specialists
Omaha, United States
University of North Carolina
Chapel Hill, United States
UH Cleveland Medical Center
Cleveland, United States
Ohio State University
Columbus, United States
Vanderbilt-Ingram Cancer Center
Nashville, United States
Virginia Cancer Specialists
Fairfax, United States
Fred Hutchinson Cancer Center
Seattle, United States
Froedtert Medical College of Wisconsin
Milwaukee, United States
Trial contact
ClinicalTrials at Perspectivetherapeutics
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/14/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.